Alexander Mark Schobel

Chief Innovation/Tech Officer, Aquestive Therapeutics, Inc.

Companies

Aquestive Therapeutics, Inc.Chief Innovation/Tech Officer Jul 24, 2018 to Oct 2, 2024¹
Aquestive Therapeutics, Inc.Board member Jul 24, 2018 to Jul 26, 2018¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 15, 2024Sold 50,000 shares at $6.00 of Aquestive Therapeutics, Inc.²
Mar 9, 2024Shares withheld for tax 5,895 shares at $4.88 of Aquestive Therapeutics, Inc.³
Mar 9, 2024Shares withheld for tax 9,645 shares at $4.88 of Aquestive Therapeutics, Inc.⁴
Mar 8, 2024Sold 25,000 shares at $5.19 of Aquestive Therapeutics, Inc.³
Mar 7, 2024Granted 82,500 shares of Aquestive Therapeutics, Inc.⁵
Mar 9, 2023Granted 100,000 shares of Aquestive Therapeutics, Inc.⁶
Jun 8, 2022Bought 45,871 shares at $0.96 of Aquestive Therapeutics, Inc.⁷

The numbers on this page point here. Each one links to the record it came from.